Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium Nasdaq:AGLE

  • George Diaz

Press/Media

Period3 Sep 2019

Media coverage

1

Media coverage

  • TitleAeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium Nasdaq:AGLE
    Media name/outletGlobal English (Middle East and North Africa Financial Network)
    Country/TerritoryJordan
    Date3/09/19
    PersonsGeorge Diaz